Glaukos (GKOS) Stock News
$GKOS · NYSE · HEALTHCARE · 4 stories in 30 daysBORSA has published 4 stories on Glaukos (GKOS) in the past 30 days, 1 of them high impact. BORSA’s news read on GKOS is bullish at 72/100, unchanged over 24 hours, based on 4 company events over the past 30 days. GKOS last closed at $165.69 on Oct 9, up 1.18% over five sessions and down 2.75% over the past month. Glaukos’ next earnings report is scheduled for Wednesday, Oct 28 after the close.
The wire on $GKOS
newest first · updated · direct subject stories onlyGlaukos reports positive Phase 4 results for iDose TR with cataract surgery
Glaukos (GKOS) said its Phase 4 trial of iDose TR given during cataract surgery met the primary endpoint, showing statistically superior IOP reduction versus cataract surgery alone. Mean diurnal IOP dropped 11.1 mmHg vs 7.4 mmHg at three months. Safety was favorable.
bullish 80 · impact 70
